US Senators Burr and Coburn introduce legislation to reform FDA

US Senators Richard Burr (Republican, North Carolina) and Tom Coburn (Republican, Oklahoma) this week introduced the Promoting Accountability, Transparency, Innovation, Efficiency and Timeliness at FDA  (PATIENTS’ FDA) Act, a bill to help make sure that the Food and Drug Administration fulfills its mission to ensure that patients have access to cutting-edge, life-saving drugs and devices as quickly as possible.

Meaningful Congressional oversight will ensure that the FDA is held accountable for its performance goals and is fulfilling its public health mission on behalf of patients in a predictable and timely manner, including decisions on life-saving drugs and devices, the Senators stated. This will help keep medical innovation and job creation from going overseas, which jeopardizes American patients’ access to the most cutting-edge medical therapies and advances.

Bill will hold FDA accountable for meeting performance goals